GordonMD Global Investments LP - Stock Holdings in 13F Filings (SEC)

Updated on March 15, 2026.

Based on 13F Filings filed with the SEC on February 17, 2026, for the 2025 Q4 period, GordonMD Global Investments LP held in its portfolio 13 assets valued at $139,492,635 (i.e. $139.49M).

The most valuable assets in the portfolio included: KYVERNA THERAPEUTICS INC ($41.28M), TEVA PHARMACEUTICAL INDS LTD ($24.02M), and BAUSCH PLUS LOMB CORP ($10.48M).

The chart below shows the top 10 valuable assets, and the table below shows the top 13 valuable assets.

You can see similar for other investment managers.

Related Topics: SEC Topic List.

Data Source: SEC.

Top Valuable Stocks in GordonMD Global Investments LP Portfolio

KYVERNA THERAPEUTICS INC

TEVA PHARMACEUTICAL INDS LTD

BAUSCH PLUS LOMB CORP

CRINETICS PHARMACEUTICALS IN

AMGEN INC

ULTRAGENYX PHARMACEUTICAL IN

TAYSHA GENE THERAPIES INC

VIR BIOTECHNOLOGY INC

TARSUS PHARMACEUTICALS INC

INCYTE CORP

GordonMD Global Investments LP - Stock Holdings in 13F Filings (SEC)

Items per page:

0 of 0

Name of Issuer	No. of Shares	Value ($)	Class
KYVERNA THERAPEUTICS INC	4391818	41283089	COM
TEVA PHARMACEUTICAL INDS LTD	769550	24017656	SPONSORED ADS
BAUSCH PLUS LOMB CORP	613472	10478102	COMMON SHARES
CRINETICS PHARMACEUTICALS IN	224135	10433484	COM
AMGEN INC	23212	7597520	COM
ULTRAGENYX PHARMACEUTICAL IN	329101	7569323	COM
TAYSHA GENE THERAPIES INC	1330901	7319956	COM SHS
VIR BIOTECHNOLOGY INC	930317	5609812	COM
TARSUS PHARMACEUTICALS INC	66680	5459758	COM
INCYTE CORP	54500	5382965	COM
INSMED INC	28587	4975281	COM PAR $.01
PYXIS ONCOLOGY INC	4121870	4740151	COM NEW
CELLDEX THERAPEUTICS INC NEW	170307	4625538	COM NEW